オンコセラピー・サイエンス(株)の日証金速報

主市場業種証券コード/EDINET英名称
東証GRT医薬品4564/E05363OncoTherapy Science,Inc.
計算日公表買残新規/返済売残新規/返済倍率
2024/08/14日証金3,871,300株
+1,357,500
1,401,700
44,200
959,300株
-231,600
16,300
247,900
4.04倍
2024/08/13日証金2,513,800株
+350,300
619,100
268,800
1,190,900株
-93,800
50,000
143,800
2.11倍
2024/08/09日証金2,163,500株
-1,180,200
809,600
1,989,800
1,284,700株
-441,000
154,300
595,300
1.68倍
2024/08/08日証金3,343,700株
-234,400
398,600
633,000
1,725,700株
+578,300
629,500
51,200
1.94倍
2024/08/07日証金3,578,100株
+435,700
463,000
27,300
1,147,400株
+73,500
95,400
21,900
3.12倍
2024/08/06日証金3,142,400株
+602,600
1,281,100
678,500
1,073,900株
+135,400
135,400
0
2.93倍
2024/08/05日証金2,539,800株
-583,500
990,500
1,574,000
938,500株
-1,977,200
2,300
1,979,500
2.71倍
2024/08/02日証金3,123,300株
+495,700
875,600
379,900
2,915,700株
-213,300
161,100
374,400
1.07倍
2024/08/01日証金2,627,600株
+457,800
1,002,800
545,000
3,129,000株
+579,500
1,366,300
786,800
0.84倍
2024/07/31日証金2,169,800株
-339,000
51,400
390,400
2,549,500株
-565,300
199,900
765,200
0.85倍
2024/07/30日証金2,508,800株
+906,200
981,900
75,700
3,114,800株
+742,300
749,000
6,700
0.81倍
2024/07/29日証金1,602,600株
-1,842,300
8,300
1,850,600
2,372,500株
+411,700
458,500
46,800
0.68倍
2024/07/26日証金3,444,900株
+769,900
799,400
29,500
1,960,800株
-812,900
119,700
932,600
1.76倍
2024/07/25日証金2,675,000株
+491,100
870,300
379,200
2,773,700株
-512,100
275,000
787,100
0.96倍
2024/07/24日証金2,183,900株
+1,399,100
1,468,600
69,500
3,285,800株
-423,500
71,500
495,000
0.66倍
2024/07/23日証金784,800株
-2,295,700
91,400
2,387,100
3,709,300株
+2,329,200
2,330,700
1,500
0.21倍
2024/07/22日証金3,080,500株
+1,603,100
1,715,700
112,600
1,380,100株
-349,200
62,600
411,800
2.23倍
2024/07/19日証金1,477,400株
-730,100
742,200
1,472,300
1,729,300株
-992,600
352,500
1,345,100
0.85倍
2024/07/18日証金2,207,500株
-156,500
110,400
266,900
2,721,900株
+357,900
414,000
56,100
0.81倍
2024/07/17日証金2,364,000株
+43,900
806,900
763,000
2,364,000株
+43,900
67,200
23,300
1倍
2024/07/16日証金2,320,100株
+577,000
818,900
241,900
2,320,100株
-804,000
88,900
892,900
1倍

※株式分割は考慮していませんのでご注意ください。

Page Top